Fever of unknown origin with rashes in early infancy is indicative of adenosine deaminase type 2 deficiency

Scand J Rheumatol. 2018 Mar;47(2):170-172. doi: 10.1080/03009742.2017.1324912. Epub 2017 Jun 30.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adenosine Deaminase / deficiency*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Exanthema / etiology
  • Female
  • Fever of Unknown Origin / etiology
  • Humans
  • Infant
  • Infliximab / therapeutic use
  • Severe Combined Immunodeficiency / diagnosis*
  • Severe Combined Immunodeficiency / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • Infliximab
  • Adenosine Deaminase
  • tocilizumab